RecruitingNot applicableNCT03787056
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Studying Gonadal germ cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hospices Civils de Lyon
- Principal Investigator
- Benoit YOU, MDHospices Civils de Lyon
- Intervention
- Blood draws(other)
- Enrollment
- 410 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2028
Study locations (17)
- Service de NEURO-ONCOLOGIE du Groupement Hospitalier EST, Bron, France
- Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'hôpital de la Croix-Rousse, Lyon, France
- Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'Hôpital E. Herriot, Lyon, France
- Service d'Oto-Rhino-Laryngologie de l'Hôpital de la Croix-Rousse, Lyon, France
- Service d'Urologie de l'Hôpital E. Herriot, Lyon, France
- Service de Gynécologie de l'hôpital de la Croix-Rousse, Lyon, France
- Service de Gynécologie du Groupement Hospitalier Est, Lyon, France
- Service de Pneumologie de l'hôpital de la Croix-Rousse, Lyon, France
- Service de Pneumologie du Groupement Hospitalier Est, Lyon, France
- Service d'Hématologie de l'Hôpital Lyon Sud, Pierre-Bénite, France
- Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE du Centre Hospitalier Lyon Sud, Pierre-Bénite, France
- Service d'Oncologie médicale du Centre hospitalier Lyon Sud, Pierre-Bénite, France
- Service d'Urologie de l'hôpital Lyon Sud, Pierre-Bénite, France
- Service de Chirurgie de l'hôpital Lyon Sud, Pierre-Bénite, France
- Service de Dermatologie de l'hôpital Lyon Sud, Pierre-Bénite, France
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03787056 on ClinicalTrials.govOther trials for Gonadal germ cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07318051Sample Collection for Ongoing Research and Product Evaluation StudyNatera, Inc.
- RECRUITINGNCT05645510LIVInG With chrONic Cancer TrEatments (LONGEVITI) StudyUniversity of Alberta
- RECRUITINGNANCT05142982Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced SeminomaTata Memorial Centre
- RECRUITINGNANCT05053230A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With CancerMemorial Sloan Kettering Cancer Center
- RECRUITINGPHASE1, PHASE2NCT04752826BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)BioInvent International AB
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04205227ENB003 Plus Pembrolizumab Phase 1b/2a in Solid TumorsENB Therapeutics, Inc
- ACTIVE NOT RECRUITINGPHASE1NCT03872947A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsToray Industries, Inc
- ACTIVE NOT RECRUITINGNANCT03418844Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of ChemotherapyCentre Francois Baclesse